Biblio
.
Measurable residual disease including AML leukemia stem cell flow evaluation of CPX-351 therapy by multi-parameter flow cytometry. Leuk Res. 2021;111:106673.
Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia. World J Stem Cells. 2013;5(4):196-204.
.
.